Xenetic Biosciences Statistics
NASDAQ: XBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.21+0.09 (+4.43%)
Market open · Delayed 15 min · as of Oct 9, 11:39 AM ET
Xenetic Biosciences by the numbers
Xenetic Biosciences has a market capitalization of $5.2 million based on 2.34M shares outstanding. With trailing EPS of $-1.15, Xenetic Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.7% below its 50-day average and 22.6% below its 200-day average.
Average daily trading volume is 87.31K shares, or about $192,960 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XBIO valuation vs. peer median
| Metric | XBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.18M | $5.06M | +2% |
| Avg. volume | 87.31K | 443.82K | -80% |
Peer median across 8 companies: NCNA, RDHL, XTLB, LNAI, ENLV, PULM, PPCB, DRMA.
Valuation
- Market cap
- $5.18M
- EPS (TTM)
- $-1.15
- Shares outstanding
- 2.34M
Price and trading
- Previous close
- 2.12
- Open
- 2.21
- Day range
- 2.21 – 2.21
- 52-week range
- 1.87 – 8.87
- Beta
- —
- Volume
- 2.28K
- Average volume
- 87.31K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 5.18M
- Forward Pe
- -3.35
- Eps
- -1.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.87
- Week52 Low
- 1.87
- Avg Volume
- 87,312.00
- Shares Outstanding
- 2.34M
- Ma50
- 3.19
- Ma200
- 2.86
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -75.08%
- Pct From52w Low
- 18.18%